Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium

Psychological Medicine

Volumn 48, Issue 1, 2018, Pages 82-94

  Walton, E ^a,b,c   Hibar, D P ^d   Van Erp, T G M ^e   Potkin, S G ^e   Roiz Santianez R ^f,g   Crespo Facorro, B ^f,g   Suarez Pinilla, P ^f,g   Van Haren, N E M ^h   De Zwarte, S M C ^h   Kahn, R S ^h   Cahn, W ^h   Doan, N T ⁱ   Jorgensen, K N ^i,j   Gurholt, T P ⁱ   Agartz, I ^i,j,k   Andreassen, O A ^i,k   Westlye, L T ⁱ   Melle, I ⁱ   Berg, A O ⁱ   Morch Johnsen, L ^i,j   Faerden A ^l   Flyckt, L ^k   Fatouros Bergman, H ^k   Jonsson E G ^i,k   Hashimoto, R ^m,n   Yamamori, H ⁿ   Fukunaga, M ^o   Jahanshad, N ^d   De Rossi, P ^p,q   Piras, F ^q,r   Banaj, N ^q   Spalletta, G ^q,s   Gur, R E ^t   Gur, R C ^t   Wolf, D H ^t   Satterthwaite, T D ^t   Beard, L M ^t   Sommer, I E ^h   Koops, S ^h   Gruber, O ^u   Richter, A ^u   Kramer B ^u   Kelly, S ^d,v   Donohoe, G ^w   McDonald, C ^w   Cannon, D M ^w   Corvin, A ^w   Gill, M ^v   Di Giorgio, A ^x   Bertolino, A ^y   Lawrie, S ^z   Nickson, T ^z   Whalley, H C ^z   Neilson, E ^z   Calhoun, V D ^aa,ab   Thompson, P M ^d   Turner, J A ^a   Ehrlich, S ^b   more..

^a GEORGIA STATE UNIVERSITY   (United States)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^g CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ UNIVERSITY OF OSLO   (Norway)

^j DIAKONHJEMMET HOSPITAL   (Norway)

^k KAROLINSKA INSTITUTE   (Sweden)

^l OSLO UNIVERSITY HOSPITAL   (Norway)

^m OSAKA UNIVERSITY   (Japan)

ⁿ OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^o NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^p SAPIENZA UNIVERSITY OF ROME   (Italy)

^q IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^r MUSEO STORICO DELLA FISICA E CENTRO STUDI E RICERCHE ENRICO FERMI   (Italy)

^s BAYLOR COLLEGE OF MEDICINE   (United States)

^t UNIVERSITY OF PENNSYLVANIA   (United States)

^u UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^v TRINITY COLLEGE DUBLIN   (Ireland)

^w NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^x CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^y UNIVERSITY OF BARI   (Italy)

^z UNIVERSITY OF EDINBURGH   (United Kingdom)

^aa MIND RESEARCH NETWORK   (United States)

^ab MSC01 1070   (United States)

more..

Author keywords

Cortical thickness; ENIGMA; FreeSurfer; medial orbitofrontal cortex; MRI; negative symptoms; PANSS; SANS; schizophrenia

Indexed keywords

ADULT; CLINICAL TRIAL; DIAGNOSTIC IMAGING; FEMALE; HEMISPHERIC DOMINANCE; HUMAN; IMAGE PROCESSING; INTERNATIONAL COOPERATION; MALE; META ANALYSIS; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREFRONTAL CORTEX; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SCHIZOPHRENIA; STATISTICAL MODEL;

ADULT; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INTERNATIONALITY; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 85039994013     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291717001283     Document Type: Article

References (85)

1. Aderhold DV, Weinmann S, Hägele C, Heinz A (2014). Frontale Hirnvolumenminderung durch Antipsychotika? Der Nervenarzt 86, 302-323.
2. Andreasen NC (1983). Scale for the Assessment of Negative Symptoms. University of Iowa: Iowa City.
3. Andreasen NC, Liu D, Ziebell S, Vora A, Ho B-C (2013). Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study. The American Journal of Psychiatry 170, 609-615.
4. Andreasen NC, Olsen S (1982). Negative v positive schizophrenia. Definition and validation. Archives of General Psychiatry 39, 789-794.
5. Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho B-C (2010). Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biological Psychiatry 67, 255-262.
6. Ansell BRE, Dwyer DB, Wood SJ, Bora E, Brewer WJ, Proffitt TM, Velakoulis D, McGorry PD, Pantelis C (2015). Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis. Psychological Medicine 45, 515-527.
7. Barch DM, Dowd EC (2010). Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions. Schizophrenia Bulletin 36, 919-934.
8. Bechara A, Damasio AR, Damasio H, Anderson SW (1994). Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 50, 7-15.
9. Bechara A, Tranel D, Damasio H (2000). Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions. Brain 123, 2189-2202.
10. Behrendt S (2014). lm.beta: Add Standardized Regression Coefficients to lm-Objects. R package version 1.5-1. http:// CRAN.R-project.org/package=lm.beta
11. Belyk M, Brown S (2014). Perception of affective and linguistic prosody: an ALE meta-analysis of neuroimaging studies. Social Cognitive and Affective Neuroscience 9, 1395-1403.
12. Berridge KC, Kringelbach ML (2015). Pleasure systems in the brain. Neuron 86, 646-664.
13. Bodnar M, Hovington CL, Buchy L, Malla AK, Joober R, Lepage M (2014). Cortical thinning in temporo-parietal junction (TPJ) in non-affective first-episode of psychosis patients with persistent negative symptoms. PLoS ONE 9, e101372.
14. Bracht T, Schnell S, Federspiel A, Razavi N, Horn H, Strik W,Wiest R, Dierks T, Müller TJ, Walther S (2013). Altered cortico-basal ganglia motor pathways reflect reduced volitional motor activity in schizophrenia. Schizophrenia Research 143, 269-276.
15. Burgdorf J, Panksepp J (2006). The neurobiology of positive emotions. Neuroscience &Biobehavioral Reviews 30, 173-187.
16. Cahn W, Hulshoff Pol HE, Lems EBTE, van Haren NEM, Schnack HG, van der Linden JA, Schothorst PF, van Engeland H, Kahn RS (2002). Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Archives of General Psychiatry 59, 1002-1010.
17. Cohen AS, Minor KS (2010). Emotional experience in patients with schizophrenia revisited: meta-analysis of laboratory studies. Schizophrenia Bulletin 36, 143-150.
18. Crespo-Facorro B, Roiz-Santiáñez R, Pérez-Iglesias R, Rodriguez-Sanchez JM, Mata I, Tordesillas-Gutierrez D, Sanchez E, Tabarés-Seisdedos R, Andreasen N, Magnotta V, Vázquez-Barquero JL (2011). Global and regional cortical thinning in first-episode psychosis patients: relationships with clinical and cognitive features. Psychological Medicine 41, 1449-1460.
19. Davidson RJ (2004). Well-being and affective style: neural substrates and biobehavioural correlates. Philosophical Transactions-Royal Society of London Series B Biological Sciences 359, 1395-1412.
20. Deserno L, Boehme R, Heinz A, Schlagenhauf F (2013). Reinforcement learning and dopamine in schizophrenia: dimensions of symptoms or specific features of a disease group? Frontiers in Psychiatry 4, 172.
21. Deserno L, Schlagenhauf F, Heinz A (2016). Striatal dopamine, reward, and decision making in schizophrenia. Dialogues in Clinical Neuroscience 18, 77-89.
22. Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ (2006). An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage 31, 968-980.
23. Ducharme S, Albaugh MD, Hudziak JJ, Botteron KN, Nguyen T-V, Truong C, Evans AC, Karama S, Ball WS, Byars AW, Schapiro M, Bommer W, Carr A, German A, Dunn S, Rivkin MJ, Waber D, Mulkern R, Vajapeyam S, Chiverton A, Davis P, Koo J, Marmor J, Mrakotsky C, Robertson R, McAnulty G, Brandt ME, Fletcher JM, Kramer LA, Yang G, McCormack C, Hebert KM, Volero H, Botteron K, McKinstry RC, Warren W, Nishino T, Almli CR, Todd R, Constantino J, McCracken JT, Levitt J, Alger J, O'Neil J, Toga A, Asarnow R, Fadale D, Heinichen L, Ireland C, Wang D-J, Moss E, Zimmerman RA, Bintliff B, Bradford R, Newman J, Evans AC, Arnaoutelis R, Pike GB, Collins DL, Leonard G, Paus T, Zijdenbos A, Das S, Fonov V, Fu L, Harlap J, Leppert I, Milovan D, Vins D, Zeffiro T, Meter JV, Lange N, Froimowitz MP, Botteron K, Almli CR, Rainey C, Henderson S, Nishino T, Warren W, Edwards JL, Dubois D, Smith K, Singer T, Wilber AA, Pierpaoli C, Basser PJ, Chang L-C, Koay CG, Walker L, Freund L, Rumsey J, Baskir L, Stanford L, Sirocco K, Gwinn-Hardy K, Spinella G, McCracken JT, Alger JR, Levitt J, O'Neill J (2014). Anxious/depressed symptoms are linked to right ventromedial prefrontal cortical thickness maturation in healthy children and young adults. Cerebral Cortex 24, 2941-2950.
24. Ehrlich S, Brauns S, Yendiki A, Ho B-C, Calhoun V, Schulz SC, Gollub RL, Sponheim SR (2012). Associations of cortical thickness and cognition in patients with schizophrenia and healthy controls. Schizophrenia Bulletin 38, 1050-1062.
25. Fellows LK, Farah MJ (2005). Different underlying impairments in decision-making following ventromedial and dorsolateral frontal lobe damage in humans. Cerebral Cortex 15, 58-63.
26. Fisher T, Shamay-Tsoory SG, Eran A, Aharon-Peretz J (2011). Characterization of recovery and neuropsychological consequences of orbitofrontal lesion: a case study. Neurocase 17, 285-293.
27. Furuyashiki T, Gallagher M (2007). Neural encoding in the orbitofrontal cortex related to goal-directed behavior. Annals of the New York Academy of Sciences 1121, 193-215.
28. Geisler D, Walton E, Naylor M, Roessner V, Lim KO, Charles Schulz S, Gollub RL, Calhoun VD, Sponheim SR, Ehrlich S (2015). Brain structure and function correlates of cognitive subtypes in schizophrenia. Psychiatry Research 234, 74-83.
29. Gold JM, Waltz JA, Matveeva TM, Kasanova Z, Strauss GP, Herbener ES, Collins AGE, Frank MJ (2012). Negative symptoms and the failure to represent the expected reward value of actions: behavioral and computational modeling evidence. Archives of General Psychiatry 69, 129-138.
30. Goldman AL (2009). Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritability. Archives of General Psychiatry 66, 467.
31. Grabenhorst F, Rolls ET (2011). Value, pleasure and choice in the ventral prefrontal cortex. Trends in Cognitive Sciences 15, 56-67.
32. Grabner RH, Fink A, Neubauer AC (2007). Brain correlates of self-rated originality of ideas: evidence from event-related power and phase-locking changes in the EEG. Behavioral Neuroscience 121, 224-230.
33. Haggard P (2008). Human volition: towards a neuroscience of will. Nature Reviews Neuroscience 9, 934-946.
34. Hartz SM, Ho B-C, Andreasen NC, Librant A, Rudd D, Epping EA, Wassink TH (2010). G72 influences longitudinal change in frontal lobe volume in schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 153B, 640-647.
35. Harvey P-O, Armony J, Malla A, Lepage M (2010). Functional neural substrates of self-reported physical anhedonia in non-clinical individuals and in patients with schizophrenia. Journal of Psychiatric Research 44, 707-716.
36. Harvey P-O, Pruessner J, Czechowska Y, Lepage M (2007). Individual differences in trait anhedonia: a structural and functional magnetic resonance imaging study in non-clinical subjects. Molecular Psychiatry 12, 767-775.
37. Ho B, Andreasen N, Ziebell S, Pierson R, Magnotta V (2011). Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Archives of General Psychiatry 68, 128-137.
38. Honea R, Crow TJ, Passingham D, Mackay CE (2005). Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry 162, 2233-2245.
39. Hornak J, Bramham J, Rolls ET, Morris RG, O'Doherty J, Bullock PR, Polkey CE (2003). Changes in emotion after circumscribed surgical lesions of the orbitofrontal and cingulate cortices. Brain: A Journal of Neurology 126, 1691-1712.
40. Jablensky A (2006). Subtyping schizophrenia: implications for genetic research. Molecular Psychiatry 11, 815-836.
41. Jeppesen P, Petersen L, Thorup A, Abel M-B, Ohlenschlæger J, Christensen TO, Krarup G, Jørgensen P, Nordentoft M (2008). The association between pre-morbid adjustment, duration of untreated psychosis and outcome in first-episode psychosis. Psychological Medicine 38, 1157-1166.
42. Kalkstein S, Hurford I, Gur RC (2010). Neurocognition in schizophrenia. Current Topics in Behavioral Neurosciences 4, 373-390.
43. Kawasaki Y, Suzuki M, Nohara S, Hagino H, Takahashi T, Matsui M, Yamashita I, Chitnis XA, McGuire PK, Seto H, Kurachi M (2004). Structural brain differences in patients with schizophrenia and schizotypal disorder demonstrated by voxel-based morphometry. European Archives of Psychiatry and Clinical Neuroscience 254, 406-414.
44. Kawasaki Y, Suzuki M, Takahashi T, Nohara S, McGuire PK, Seto H, Kurachi M (2008). Anomalous cerebral asymmetry in patients with schizophrenia demonstrated by voxel-based morphometry. Biological Psychiatry 63, 793-800.
45. Kay SR, Fiszbein A, Opler LA (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia bulletin 13, 261-276.
46. Kringelbach ML, Rolls ET (2004). The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Progress in Neurobiology 72, 341-372.
47. Kühn S, Gallinat J (2012). The neural correlates of subjective pleasantness. NeuroImage 61, 289-294.
48. Lesh TA, Tanase C, Geib BR, Niendam TA, Yoon JH, Minzenberg MJ, Ragland JD, Solomon M, Carter CS (2015). A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia. JAMA Psychiatry 72, 226-234.
49. Liu X, Hairston J, Schrier M, Fan J (2011). Common and distinct networks underlying reward valence and processing stages: a meta-analysis of functional neuroimaging studies. Neuroscience &Biobehavioral Reviews 35, 1219-1236.
50. McKechanie AG, Moorhead TWJ, Stanfield AC, Whalley HC, Johnstone EC, Lawrie SM, Owens DGC (2015). Negative symptoms and longitudinal grey matter tissue loss in adolescents at risk of psychosis: preliminary findings from a 6-year follow-up study. The British Journal of Psychiatry 6, 565-570.
51. Milev P, Ho B-C, Arndt S, Andreasen NC (2005). Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: A longitudinal first-episode study with 7-year follow-up. American Journal of Psychiatry 162, 495-506.
52. Mørch-Johnsen L, Nesvåg R, Faerden A, Haukvik UK, Jørgensen KN, Lange EH, Andreassen OA, Melle I, Agartz I (2015). Brain structure abnormalities in first-episode psychosis patients with persistent apathy. Schizophrenia Research 164, 59-64.
53. Nenadic I, Yotter RA, Sauer H, Gaser C (2015). Patterns of cortical thinning in different subgroups of schizophrenia. The British Journal of Psychiatry: the Journal of Mental Science 206, 479-483.
54. Nesvåg R, Lawyer G, Varnäs K, Fjell AM, Walhovd KB, Frigessi A, Jönsson EG, Agartz I (2008). Regional thinning of the cerebral cortex in schizophrenia: effects of diagnosis, age and antipsychotic medication. Schizophrenia Research 98, 16-28.
55. Oertel-Knöchel V, Knöchel C, Rotarska-Jagiela A, Reinke B, Prvulovic D, Haenschel C, Hampel H, Linden DEJ (2013). Association between psychotic symptoms and cortical thickness reduction across the schizophrenia spectrum. Cerebral Cortex 23, 61-70.
56. Pessoa L (2009). How do emotion and motivation direct executive control? Trends in Cognitive Sciences 13, 160-166.
57. Peters J, Büchel C (2010). Neural representations of subjective reward value. Behavioural Brain Research 213, 135-141.
58. Plailly J, d'Amato T, Saoud M, Royet J-P (2006). Left temporo-limbic and orbital dysfunction in schizophrenia during odor familiarity and hedonicity judgments. NeuroImage 29, 302-313.
59. Price TF, Harmon-Jones E (2011). Approach motivational body postures lean toward left frontal brain activity. Psychophysiology 48, 718-722.
60. R Development Core Team (2008). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria.
61. Radua J, Schmidt A, Borgwardt S, Heinz A, Schlagenhauf F, McGuire P, Fusar-Poli P (2015). Ventral striatal activation during reward processing in psychosis: a neurofunctional meta-analysis. JAMA Psychiatry 72, 1243-1251.
62. Rimol LM, Hartberg CB, Nesvåg R, Fennema-Notestine C, Hagler Jr. DJ, Pung CJ, Jennings RG, Haukvik UK, Lange E, Nakstad PH, Melle I, Andreassen OA, Dale AM, Agartz I (2010). Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biological Psychiatry 68, 41-50.
63. Roesch MR, Olson CR (2007). Neuronal activity related to anticipated reward in frontal cortex: does it represent value or reflect motivation? Annals of the New York Academy of Sciences 1121, 431-446.
64. Rosenheck R, Leslie D, Keefe R, McEvoy J, Swartz M, Perkins D, Stroup S, Hsiao JK, Lieberman J (2006). Barriers to employment for people with schizophrenia. American Journal of Psychiatry 163, 411-417.
65. Schlagenhauf F, Huys QJM, Deserno L, Rapp MA, Beck A, Heinze H-J, Dolan R, Heinz A (2014). Striatal dysfunction during reversal learning in unmedicated schizophrenia patients. NeuroImage 89, 171-180.
66. Schlagenhauf F, Sterzer P, Schmack K, Ballmaier M, Rapp M, Wrase J, Juckel G, Gallinat J, Heinz A (2009). Reward feedback alterations in unmedicated schizophrenia patients: relevance for delusions. Biological Psychiatry 65, 1032-1039.
67. Schultz CC, Koch K, Wagner G, Roebel M, Schachtzabel C, Gaser C, Nenadic I, Reichenbach JR, Sauer H, Schlösser RGM (2010). Reduced cortical thickness in first episode schizophrenia. Schizophrenia Research 116, 204-209.
68. Segarra N, Metastasio A, Ziauddeen H, Spencer J, Reinders NR, Dudas RB, Arrondo G, Robbins TW, Clark L, Fletcher PC, Murray GK (2016). Abnormal frontostriatal activity during unexpected reward receipt in depression and schizophrenia: relationship to anhedonia. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 41, 2001-2010.
69. Simon JJ, Cordeiro SA, Weber M-A, Friederich H-C, Wolf RC, Weisbrod M, Kaiser S (2015). Reward system dysfunction as a neural substrate of symptom expression across the general population and patients with schizophrenia. Schizophrenia Bulletin 41, 1370-1378.
70. Strauss GP, Frank MJ, Waltz JA, Kasanova Z, Herbener ES, Gold JM (2011). Deficits in positive reinforcement learning and uncertainty-driven exploration are associated with distinct aspects of negative symptoms in schizophrenia. Biological Psychiatry 69, 424-431.
71. Suzuki M, Nohara S, Hagino H, Kurokawa K, Yotsutsuji T, Kawasaki Y, Takahashi T, Matsui M, Watanabe N, Seto H, Kurachi M (2002). Regional changes in brain gray and white matter in patients with schizophrenia demonstrated with voxel-based analysis of MRI. Schizophrenia Research 55, 41-54.
72. Szatkowska I, Bogorodzki P, Wolak T, Marchewka A, Szeszkowski W (2008). The effect of motivation on working memory: an fMRI and SEM study. Neurobiology of Learning and Memory 90, 475-478.
73. Takeuchi H, Taki Y, Nouchi R, Sekiguchi A, Kotozaki Y, Miyauchi CM, Yokoyama R, Iizuka K, Hashizume H, Nakagawa S, Kunitoki K, Sassa Y, Kawashima R (2014). Regional gray matter density is associated with achievement motivation: evidence from voxel-based morphometry. Brain Structure &Function 219, 71-83.
74. Tregellas JR, Shatti S, Tanabe JL, Martin LF, Gibson L, Wylie K, Rojas DC (2007). Gray matter volume differences and the effects of smoking on gray matter in schizophrenia. Schizophrenia Research 97, 242-249.
75. van Erp TGM, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, Donohoe G, Kelly S, McDonald C, Morris DW, Cannon DM, Corvin A, Machielsen MWJ, Koenders L, de Haan L, Veltman DJ, Satterthwaite TD, Wolf DH, Gur RC, Gur RE, Potkin SG, Mathalon DH, Mueller BA, Preda A, Macciardi F, Ehrlich S, Walton E, Hass J, Calhoun VD, Bockholt HJ, Sponheim SR, Shoemaker JM, van Haren NEM, Pol HEH, Ophoff RA, Kahn RS, Roiz-Santiañez R, Crespo-Facorro B, Wang L, Alpert KI, Jönsson EG, Dimitrova R, Bois C, Whalley HC, McIntosh AM, Lawrie SM, Hashimoto R, Thompson PM, Turner JA (2015). Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Molecular Psychiatry 21, 547-553.
76. van Erp TGM, Preda A, Nguyen D, Faziola L, Turner J, Bustillo J, Belger A, Lim KO, McEwen S, Voyvodic J, Mathalon DH, Ford J, Potkin SG, Fbirn (2014). Converting positive and negative symptom scores between PANSS and SAPS/SANS. Schizophrenia Research 152, 289-294.
77. van Haren NM, Schnack HG, CahnW, van den HeuvelMP, Lepage C, Collins L, Evans AC, Hulshoff Pol HE, Kahn RS (2011).Changes incortical thicknessduringthe course of illness in schizophrenia. Archives of General Psychiatry 68, 871-880.
78. Venkatasubramanian G, Jayakumar PN, Gangadhar BN, Keshavan MS (2008). Automated MRI parcellation study of regional volume and thickness of prefrontal cortex (PFC) in antipsychotic-naïve schizophrenia. Acta Psychiatrica Scandinavica 117, 420-431.
79. Viechtbauer (2010). Conducting meta-analyses in R with the metafor package. Journal of Statistical Software 36, 1-48.
80. Vita A, De Peri L, Deste G, Barlati S, Sacchetti E (2015). The effect of antipsychotic treatment on cortical gray matter changes in schizophrenia: does the class matter? A meta-analysis and meta-regression of longitudinal magnetic resonance imaging studies. Biological Psychiatry 78, 403-412.
81. Waltz JA, Frank MJ, Robinson BM, Gold JM (2007). Selective reinforcement learning deficits in schizophrenia support predictions from computational models of striatal-cortical dysfunction. Biological Psychiatry 62, 756-764.
82. Woods SW (2003). Chlorpromazine equivalent doses for the newer atypical antipsychotics. The Journal of Clinical Psychiatry 64, 663-667.
83. Xiao L, Xu H, Zhang Y, Wei Z, He J, Jiang W, Li X, Dyck LE, Devon RM, Deng Y, Li XM (2008). Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes. Molecular Psychiatry 13, 697-708.
84. Xiao Y, Lui S, Deng W, Yao L, Zhang W, Li S, Wu M, Xie T, He Y, Huang X, Hu J, Bi F, Li T, Gong Q (2015). Altered cortical thickness related to clinical severity but not the untreated disease duration in schizophrenia. Schizophrenia Bulletin 41, 201-210.
85. Zald DH, McHugo M, Ray KL, Glahn DC, Eickhoff SB, Laird AR (2014). Meta-analytic connectivity modeling reveals differential functional connectivity of the medial and lateral orbitofrontal cortex. Cerebral Cortex 24, 232-248.